Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2019
  • Number of employees in Switzerland
    1-9